Clinical trial
Prolonged Low Doses of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome
NCT04323592 is registered in ClinicalTrials.gov with University of Trieste as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prolonged Low Doses of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome
- Lead sponsor
- University of Trieste
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 23, 2020
- Completion date
- May 10, 2020
- Enrollment
- 173 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ards, human, coronavirus infections, severe acute respiratory syndrome (sars) pneumonia